Skip to content
PICO Portalanswers from OpenAlex

Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease

PaperCitations, authors & open-access status

Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease have?

PICO Portalcitation count

Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease has 114 citations in the OpenAlex counts PICO Portal stores.

When was Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease published?

PICO Portalyear

Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease has 2012 year in the PICO Portal index.

What is the open-access status of Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease?

PICO Portaloa status

Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease has closed oa status in the PICO Portal index.

What is the DOI of Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease?

PICO Portaldoi

The DOI for Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease is on the source record.

What is the PMID of Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease?

PICO Portalpmid

The PMID for Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease is on the source record.

What is the OpenAlex record for Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease?

PICO Portalopenalex

The OpenAlex for Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial